{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T15:16:52Z","timestamp":1787325412605,"version":"build-2736575974"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,25]],"date-time":"2025-11-25T00:00:00Z","timestamp":1764028800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,11,25]],"date-time":"2025-11-25T00:00:00Z","timestamp":1764028800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100012131","name":"Department of Science & Technology of Liaoning Province","doi-asserted-by":"crossref","award":["2023-BSBA-212"],"award-info":[{"award-number":["2023-BSBA-212"]}],"id":[{"id":"10.13039\/501100012131","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100020761","name":"Liaoning Cancer Hospital & Institute","doi-asserted-by":"crossref","award":["2024-ZLKF-10"],"award-info":[{"award-number":["2024-ZLKF-10"]}],"id":[{"id":"10.13039\/501100020761","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100007300","name":"China Medical University","doi-asserted-by":"publisher","award":["3110210603"],"award-info":[{"award-number":["3110210603"]}],"id":[{"id":"10.13039\/501100007300","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Nanobiotechnol"],"DOI":"10.1186\/s12951-025-03785-1","type":"journal-article","created":{"date-parts":[[2025,11,25]],"date-time":"2025-11-25T09:04:36Z","timestamp":1764061476000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Self-assembled phenylboronic acid nanomedicine targets sialic acid to synergistically activate ferroptosis via RRM1 suppression and GPX4 Inhibition for precision colon cancer therapy"],"prefix":"10.1186","volume":"23","author":[{"given":"Dake","family":"Song","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianing","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yidan","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qijun","family":"Hui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hengkai","family":"Qi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanrui","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Qian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanyuan","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minjie","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiutong","family":"Guan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenhua","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,25]]},"reference":[{"key":"3785_CR1","doi-asserted-by":"publisher","unstructured":"Siegel RL, Giaquinto AN, Jemal A. Cancer statistics, 2024. CA Cancer J Clin. 2024;74:12\u201349. https:\/\/doi.org\/10.3322\/caac.21820.","DOI":"10.3322\/caac.21820"},{"key":"3785_CR2","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1038\/s41571-021-00514-z","volume":"18","author":"I Soerjomataram","year":"2021","unstructured":"Soerjomataram I, Bray F. Planning for tomorrow: global cancer incidence and the role of prevention 2020-2070. Nat Rev Clin Oncol. 2021;18:663\u201372. https:\/\/doi.org\/10.1038\/s41571-021-00514-z.","journal-title":"Nat Rev Clin Oncol"},{"key":"3785_CR3","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1158\/2159-8290.CD-21-0212","volume":"12","author":"D Plana","year":"2022","unstructured":"Plana D, Palmer AC, Sorger PK. Independent drug action in combination therapy: implications for precision oncology. Cancer Discov. 2022;12:606\u201324. https:\/\/doi.org\/10.1158\/2159-8290.CD-21-0212.","journal-title":"Cancer Discov"},{"key":"3785_CR4","doi-asserted-by":"publisher","unstructured":"Ruan H, Leibowitz BJ, Zhang L, Yu J. Immunogenic cell death in colon cancer prevention and therapy. Mol Carcinog. 2020;59:783\u201393. https:\/\/doi.org\/10.1002\/mc.23183.","DOI":"10.1002\/mc.23183"},{"key":"3785_CR5","doi-asserted-by":"publisher","unstructured":"Tie J, Cohen JD, Lahouel K, Lo SN, Wang Y, Kosmider S, Wong R, Shapiro J, Lee M, Harris S, et al. Circulating tumor DNA analysis guiding adjuvant therapy in stage II colon cancer. N Engl J Med. 2022;386:2261\u201372. https:\/\/doi.org\/10.1056\/NEJMoa2200075.","DOI":"10.1056\/NEJMoa2200075"},{"key":"3785_CR6","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1038\/s41586-022-04437-2","volume":"603","author":"P Jaaks","year":"2022","unstructured":"Jaaks P, Coker EA, Vis DJ, Edwards O, Carpenter EF, Leto SM, Dwane L, Sassi F, Lightfoot H, Barthorpe S, et al. Effective drug combinations in breast, colon and pancreatic cancer cells. Nature. 2022;603:166\u201373. https:\/\/doi.org\/10.1038\/s41586-022-04437-2.","journal-title":"Nature"},{"key":"3785_CR7","doi-asserted-by":"publisher","first-page":"2363","DOI":"10.1056\/NEJMoa2201445","volume":"386","author":"A Cercek","year":"2022","unstructured":"Cercek A, Lumish M, Sinopoli J, Weiss J, Shia J, Lamendola-Essel M, El Dika IH, Segal N, Shcherba M, Sugarman R, et al. PD-1 Blockade in mismatch repair-deficient, locally advanced rectal cancer. N Engl J Med. 2022;386:2363\u201376. https:\/\/doi.org\/10.1056\/NEJMoa2201445. .","journal-title":"N Engl J Med"},{"key":"3785_CR8","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1080\/14737140.2025.2517881","volume":"25","author":"M Chan","year":"2025","unstructured":"Chan M, Krishnan T, Townsend A, Karapetis C, Roy A, Foo T, Tebbutt N, Dhillon T, Price T. The current landscape of neoadjuvant therapy for resectable colon cancer. Expert Rev Anticancer Ther. 2025;25:901\u201313. https:\/\/doi.org\/10.1080\/14737140.2025.2517881.","journal-title":"Expert Rev Anticancer Ther"},{"key":"3785_CR9","doi-asserted-by":"publisher","first-page":"1949","DOI":"10.1056\/NEJMoa2400634","volume":"390","author":"M Chalabi","year":"2024","unstructured":"Chalabi M, Verschoor YL, Tan PB, Balduzzi S, Van Lent AU, Grootscholten C, Dokter S, B\u00fcller NV, Grotenhuis BA, Kuhlmann K, et al. Neoadjuvant immunotherapy in locally advanced mismatch repair-deficient colon cancer. N Engl J Med. 2024;390:1949\u201358. https:\/\/doi.org\/10.1056\/NEJMoa2400634.","journal-title":"N Engl J Med"},{"key":"3785_CR10","doi-asserted-by":"publisher","unstructured":"Restifo NP, Smyth MJ, Snyder A. Acquired resistance to immunotherapy and future challenges. Nat Rev Cancer. 2016;16:121\u201326. https:\/\/doi.org\/10.1038\/nrc.2016.2.","DOI":"10.1038\/nrc.2016.2"},{"key":"3785_CR11","doi-asserted-by":"publisher","first-page":"245","DOI":"10.3390\/cells13030245","volume":"13","author":"PW Underwood","year":"2024","unstructured":"Underwood PW, Ruff SM, Pawlik TM. Update on targeted therapy and immunotherapy for metastatic colorectal cancer. Cells. 2024;13:245. https:\/\/doi.org\/10.3390\/cells13030245.","journal-title":"Cells"},{"key":"3785_CR12","doi-asserted-by":"publisher","first-page":"114212","DOI":"10.1016\/j.intimp.2025.114212","volume":"149","author":"X Li","year":"2025","unstructured":"Li X, Dong Y, Wang T, Huang K, Guo W, Xu L, Gu Y. Chemotherapy boosts anti-angiogenic and anti-PD-1 combination therapy through activation of cCAS-STING pathway in colon cancer. Int Immunopharmacol. 2025;149:114212. https:\/\/doi.org\/10.1016\/j.intimp.2025.114212.","journal-title":"Int Immunopharmacol"},{"key":"3785_CR13","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1016\/j.cell.2012.03.042","volume":"149","author":"SJ Dixon","year":"2012","unstructured":"Dixon SJ, Lemberg KM, Lamprecht MR, Skouta R, Zaitsev EM, Gleason CE, Patel DN, Bauer AJ, Cantley AM, Yang W, et al. Ferroptosis: an iron-dependent form of nonapoptotic cell death. Cell. 2012;149:1060\u201372. https:\/\/doi.org\/10.1016\/j.cell.2012.03.042.","journal-title":"Cell"},{"key":"3785_CR14","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/j.cell.2017.09.021","volume":"171","author":"BR Stockwell","year":"2017","unstructured":"Stockwell BR, Friedmann Angeli JP, Bayir H, Bush AI, Conrad M, Dixon SJ, Fulda S, Gasc\u00f3n S, Hatzios SK, Kagan VE, et al. Ferroptosis: a regulated cell death nexus linking metabolism, redox biology, and disease. Cell. 2017;171:273\u201385. https:\/\/doi.org\/10.1016\/j.cell.2017.09.021.","journal-title":"Cell"},{"key":"3785_CR15","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1038\/s41392-020-00428-9","volume":"6","author":"H Yan","year":"2021","unstructured":"Yan H, Zou T, Tuo Q, Xu S, Li H, Belaidi AA, Lei P. Ferroptosis: mechanisms and links with diseases. Signal Transduct Target Ther. 2021;6:49. https:\/\/doi.org\/10.1038\/s41392-020-00428-9.","journal-title":"Signal Transduct Target Ther"},{"key":"3785_CR16","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1038\/s41568-022-00459-0","volume":"22","author":"G Lei","year":"2022","unstructured":"Lei G, Zhuang L, Gan B. Targeting ferroptosis as a vulnerability in cancer. Nat Rev Cancer. 2022;22:381\u201396. https:\/\/doi.org\/10.1038\/s41568-022-00459-0.","journal-title":"Nat Rev Cancer"},{"key":"3785_CR17","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1002\/cac2.12250","volume":"42","author":"L Zhao","year":"2022","unstructured":"Zhao L, Zhou X, Xie F, Zhang L, Yan H, Huang J, Zhang C, Zhou F, Chen J, Zhang L. Ferroptosis in cancer and cancer immunotherapy. Cancer Commun. 2022;42:88\u2013116. https:\/\/doi.org\/10.1002\/cac2.12250.","journal-title":"Cancer Commun"},{"key":"3785_CR18","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1016\/j.ajps.2022.07.006","volume":"17","author":"Z Zhang","year":"2022","unstructured":"Zhang Z, Ji Y, Hu N, Yu Q, Zhang X, Li J, Wu F, Xu H, Tang Q, Li X. Ferroptosis-induced anticancer effect of Resveratrol with a biomimetic nano-delivery system in colorectal cancer treatment. Asian J Pharm Sci. 2022;17:751\u201366. https:\/\/doi.org\/10.1016\/j.ajps.2022.07.006.","journal-title":"Asian J Pharm Sci"},{"key":"3785_CR19","doi-asserted-by":"publisher","unstructured":"Tan H, Shen Z, Wang X, Shu S, Deng J, Lu L, Fan Z, Hu D, Cheng P, Cao X, et al. Endoplasmic reticulum-targeted biomimetic nanoparticles induce apoptosis and ferroptosis by regulating Endoplasmic reticulum function in colon cancer. J Control Release. 2024;375:422\u201337. https:\/\/doi.org\/10.1016\/j.jconrel.2024.09.018.","DOI":"10.1016\/j.jconrel.2024.09.018"},{"key":"3785_CR20","doi-asserted-by":"publisher","unstructured":"Liu J, Wu M, Yang C, Zhou Y, Qi X, Chen K, Zhang X, Fan N, Zhan C, Wang W. Synergizing ferroptosis suppressor protein 1 gene Silencing and photodynamic therapy based on photosensitive lipid nanoparticles for colon cancer immunotherapy. ACS Nano. 2025;19:29341\u201359. https:\/\/doi.org\/10.1021\/acsnano.5c06115.","DOI":"10.1021\/acsnano.5c06115"},{"key":"3785_CR21","doi-asserted-by":"publisher","first-page":"5451","DOI":"10.3390\/molecules27175451","volume":"27","author":"C Abe","year":"2022","unstructured":"Abe C, Miyazawa T, Miyazawa T. Current use of Fenton reaction in drugs and food. Molecules. 2022;27:5451. https:\/\/doi.org\/10.3390\/molecules27175451.","journal-title":"Molecules"},{"key":"3785_CR22","doi-asserted-by":"publisher","first-page":"979","DOI":"10.2217\/nnm-2024-0007","volume":"19","author":"MM Abu-Serie","year":"2024","unstructured":"Abu-Serie MM. Synergistic eradicating impact of 5-fluouracil with FeO nanoparticles-diethyldithiocarbamate in colon cancer spheroids. Nanomed (Lond). 2024;19:979\u201394. https:\/\/doi.org\/10.2217\/nnm-2024-0007.","journal-title":"Nanomed (Lond)"},{"key":"3785_CR23","doi-asserted-by":"publisher","first-page":"5784","DOI":"10.1039\/D2TB01242A","volume":"10","author":"J Lin","year":"2022","unstructured":"Lin J, Zhang J, Wang K, Guo S, Yang W. Zwitterionic polymer coated sorafenib-loaded Fe3O4 composite nanoparticles induced ferroptosis for cancer therapy. J Mater Chem B. 2022;10:5784\u201395. https:\/\/doi.org\/10.1039\/D2TB01242A.","journal-title":"J Mater Chem B"},{"key":"3785_CR24","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1186\/s12951-024-02747-3","volume":"22","author":"Y Sun","year":"2024","unstructured":"Sun Y, Ma Y-Y, Shangguan S, Ruan Y, Bai T, Xue P, Zhuang H, Cao W, Cai H, Tang E, et al. Metal ions-anchored bacterial outer membrane vesicles for enhanced ferroptosis induction and immune stimulation in targeted antitumor therapy. J Nanobiotechnol. 2024;22:474. https:\/\/doi.org\/10.1186\/s12951-024-02747-3.","journal-title":"J Nanobiotechnol"},{"key":"3785_CR25","doi-asserted-by":"publisher","first-page":"2701","DOI":"10.1007\/s12011-024-04360-9","volume":"203","author":"IP Taufani","year":"2025","unstructured":"Taufani IP, Tasminatun S, Harimurti S, Yang LY, Huang CY, Situmorang JH. Tannic acid suppresses ferroptosis induced by iron Salophene complex in kidney cells and prevents iron overload-induced liver and kidney dysfunction in rats. Biol Trace Elem Res. 2025;203:2701\u201313. https:\/\/doi.org\/10.1007\/s12011-024-04360-9.","journal-title":"Biol Trace Elem Res"},{"key":"3785_CR26","doi-asserted-by":"publisher","unstructured":"Yang WS, SriRamaratnam R, Welsch ME, Shimada K, Skouta R, Viswanathan VS, Cheah JH, Clemons PA, Shamji AF, Clish CB, et al. Regulation of ferroptotic cancer cell death by GPX4. Cell. 2014;156:317\u201331. https:\/\/doi.org\/10.1016\/j.cell.2013.12.010.","DOI":"10.1016\/j.cell.2013.12.010"},{"key":"3785_CR27","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.freeradbiomed.2020.02.027","volume":"152","author":"F Ursini","year":"2020","unstructured":"Ursini F, Maiorino M. Lipid peroxidation and ferroptosis: the role of GSH and GPX4. Free Radic Biol Med. 2020;152:175\u201385. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2020.02.027.","journal-title":"Free Radic Biol Med"},{"key":"3785_CR28","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1016\/j.cell.2017.11.048","volume":"172","author":"I Ingold","year":"2018","unstructured":"Ingold I, Berndt C, Schmitt S, Doll S, Poschmann G, Buday K, Roveri A, Peng X, Porto Freitas F, Seibt T, et al. Selenium utilization by GPX4 is required to prevent hydroperoxide-induced ferroptosis. Cell. 2018;172:409\u201322. https:\/\/doi.org\/10.1016\/j.cell.2017.11.048.","journal-title":"Cell"},{"key":"3785_CR29","doi-asserted-by":"publisher","unstructured":"Ruan Y, Zhuang H, Zeng X, Lin L, Wang X, Xue P, Xu S, Chen Q, Yan S, Huang W. Engineered microbial nanohybrids for tumor-mediated NIR II photothermal enhanced ferroptosis\/cuproptosis and immunotherapy. Adv Healthc Mater. 2024;13:e2302537. https:\/\/doi.org\/10.1002\/adhm.202302537.","DOI":"10.1002\/adhm.202302537"},{"key":"3785_CR30","doi-asserted-by":"publisher","unstructured":"Efferth T. From ancient herb to modern drug: Artemisia annua and Artemisinin for cancer therapy. Semin Cancer Biol. 2017;46:65\u201383. https:\/\/doi.org\/10.1016\/j.semcancer.2017.02.009.","DOI":"10.1016\/j.semcancer.2017.02.009"},{"key":"3785_CR31","doi-asserted-by":"publisher","first-page":"28879","DOI":"10.1021\/acsami.3c01499","volume":"15","author":"W Chen","year":"2023","unstructured":"Chen W, Xie L, Lv C, Song E, Zhu X, Song Y. Transferrin-targeted cascade nanoplatform for inhibiting transcription factor nuclear factor erythroid 2-related factor 2 and enhancing ferroptosis anticancer therapy. ACS Appl Mater Interfaces. 2023;15:28879\u201390. https:\/\/doi.org\/10.1021\/acsami.3c01499.","journal-title":"ACS Appl Mater Interfaces"},{"key":"3785_CR32","doi-asserted-by":"publisher","unstructured":"Efferth T, Kaina B, Shen S, Liao Q, Lyu M, Wong YK, Zhang X, Zhou J, Ma N, Wang J. Toxicity of the antimalarial Artemisinin and its derivatives. Crit Rev ToxicolPharmacol Ther. 20102020;40:405\u201321. https:\/\/doi.org\/10.3109\/10408441003610571.","DOI":"10.3109\/10408441003610571"},{"key":"3785_CR33","doi-asserted-by":"publisher","unstructured":"33.Shen S, Liao Q, Lyu M, Wong YK, Zhang X, Zhou J, Ma N, Wang J. The potential of artemisinins as anti-obesity agents via modulating the immune system. Pharmacol Ther. 2020;216:107696 https:\/\/doi.org\/10.1016\/j.pharmthera.2020.107696.","DOI":"10.1016\/j.pharmthera.2020.107696"},{"key":"3785_CR34","doi-asserted-by":"publisher","first-page":"13666","DOI":"10.1021\/acs.jmedchem.4c00208","volume":"67","author":"J Zhang","year":"2024","unstructured":"Zhang J, Chen X, Chen C, Li F, Song X, Liu C, Liao K, Su MY, Tan CSH, Fang L, et al. Distinct amino acid-based PROTACS target oncogenic kinases for degradation in non-small cell lung cancer (NSCLC). J Med Chem. 2024;67:13666\u201380. https:\/\/doi.org\/10.1021\/acs.jmedchem.4c00208.","journal-title":"J Med Chem"},{"key":"3785_CR35","doi-asserted-by":"publisher","first-page":"111909","DOI":"10.1016\/j.ejmech.2019.111909","volume":"187","author":"P Singla","year":"2020","unstructured":"Singla P, Salunke DB. Recent advances in steroid amino acid conjugates: old scaffolds with new dimensions. Eur J Med Chem. 2020;187:111909. https:\/\/doi.org\/10.1016\/j.ejmech.2019.111909.","journal-title":"Eur J Med Chem"},{"key":"3785_CR36","doi-asserted-by":"publisher","first-page":"1168","DOI":"10.1016\/j.jconrel.2020.11.024","volume":"330","author":"J Lim","year":"2021","unstructured":"Lim J, Lee J, Jung S, Kim WJ. Phenylboronic-acid-based nanocomplex as a feasible delivery platform of immune checkpoint inhibitor for potent cancer immunotherapy. J Control Release. 2021;330:1168\u201377. https:\/\/doi.org\/10.1016\/j.jconrel.2020.11.024.","journal-title":"J Control Release"},{"key":"3785_CR37","doi-asserted-by":"publisher","first-page":"120551","DOI":"10.1016\/j.biomaterials.2020.120551","volume":"268","author":"A Kim","year":"2021","unstructured":"Kim A, Suzuki M, Matsumoto Y, Fukumitsu N, Nagasaki Y. Non-isotope enriched Phenylboronic acid-decorated dual-functional nano-assembles for an actively targeting BNCT drug. Biomaterials. 2021;268:120551. https:\/\/doi.org\/10.1016\/j.biomaterials.2020.120551.","journal-title":"Biomaterials"},{"key":"3785_CR38","doi-asserted-by":"publisher","first-page":"128415","DOI":"10.1016\/j.ijbiomac.2023.128415","volume":"257","author":"M Ghosh","year":"2024","unstructured":"Ghosh M, Hazarika P, Dhanya SJ, Pooja D, Kulhari H. Exploration of Sialic acid receptors as a potential target for cancer treatment: a comprehensive review. Int J Biol Macromol. 2024;257:128415. https:\/\/doi.org\/10.1016\/j.ijbiomac.2023.128415.","journal-title":"Int J Biol Macromol"},{"key":"3785_CR39","doi-asserted-by":"publisher","first-page":"1","DOI":"10.15212\/bioi-2024-0107","volume":"6","author":"AS Chauhan","year":"2025","unstructured":"Chauhan AS, Chand P, Parashar T. Lipid-based nanoparticles: strategy for targeted cancer therapy. BIO Integr. 2025;6:1\u201323. https:\/\/doi.org\/10.15212\/bioi-2024-0107.","journal-title":"BIO Integr"},{"key":"3785_CR40","doi-asserted-by":"publisher","unstructured":"He S, Fu Y, Tan Z, Jiang Q, Huang K, Saw PE, Nie Y, Guo M. Optimization of ultra-small nanoparticles for enhanced drug delivery. BIO Integration. 2023;4:62-9. https:\/\/doi.org\/10.15212\/bioi-2022-0015.","DOI":"10.15212\/bioi-2022-0015."},{"key":"3785_CR41","doi-asserted-by":"publisher","first-page":"100046","DOI":"10.1016\/j.pscia.2024.100046","volume":"2","author":"Y Yao","year":"2024","unstructured":"Yao Y, Hu Y, Meng X, Feng F, Xu F, Wang G, Yu H, Li J. Dual-targeting liposomal delivery of Sorafenib and docetaxel for enhanced synergistic therapy in advanced hepatocellular carcinoma. Pharm Sci Adv. 2024;2:100046. https:\/\/doi.org\/10.1016\/j.pscia.2024.100046.","journal-title":"Pharm Sci Adv"},{"key":"3785_CR42","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1186\/s12885-017-3925-x","volume":"18","author":"J Engstrand","year":"2018","unstructured":"Engstrand J, Nilsson H, Str\u00f6mberg C, Jonas E, Freedman J. Colorectal cancer liver metastases-a population-based study on incidence, management and survival. BMC Cancer. 2018;18:78. https:\/\/doi.org\/10.1186\/s12885-017-3925-x.","journal-title":"BMC Cancer"},{"key":"3785_CR43","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1208\/s12249-014-0107-x","volume":"15","author":"M Narvekar","year":"2014","unstructured":"Narvekar M, Xue HY, Eoh JY, Wong HL. Nanocarrier for poorly water-soluble anticancer drugs-barriers of translation and solutions. AAPS PharmSciTech. 2014;15:822\u201333. https:\/\/doi.org\/10.1208\/s12249-014-0107-x.","journal-title":"AAPS PharmSciTech"},{"key":"3785_CR44","doi-asserted-by":"publisher","first-page":"10979","DOI":"10.1021\/acsnano.3c11154","volume":"18","author":"G Liang","year":"2024","unstructured":"Liang G, Cao W, Tang D, Zhang H, Yu Y, Ding J, Karges J, Xiao H, Nanomedomics. ACS Nano. 2024;18:10979\u20131024. https:\/\/doi.org\/10.1021\/acsnano.3c11154.","journal-title":"ACS Nano"},{"key":"3785_CR45","doi-asserted-by":"publisher","first-page":"100055","DOI":"10.1016\/j.pscia.2024.100055","volume":"2","author":"PB Lokole","year":"2024","unstructured":"Lokole PB, Ngombe NK, Motomba DI, Safari JB, Mpuza MK, Krause RWM, Mutwale PK, Nkanga CI. Preparation and characterization of micellar nanoparticles using crude saponins from five Congolese plant species. Pharm Sci Adv. 2024;2:100055. https:\/\/doi.org\/10.1016\/j.pscia.2024.100055.","journal-title":"Pharm Sci Adv"},{"key":"3785_CR46","doi-asserted-by":"publisher","first-page":"4067","DOI":"10.1021\/acs.jproteome.4c00400","volume":"23","author":"Y Wang","year":"2024","unstructured":"Wang Y, Zhang L, Xu L, Ma J. The proteomic landscape of monocytes in response to colorectal cancer cells. J Proteome Res. 2024;23:4067\u201381. https:\/\/doi.org\/10.1021\/acs.jproteome.4c00400.","journal-title":"J Proteome Res"},{"key":"3785_CR47","doi-asserted-by":"publisher","first-page":"30566","DOI":"10.34172\/bi.30566","volume":"15","author":"E Nazari","year":"2024","unstructured":"Nazari E, Khalili-Tanha G, Pourali G, Khojasteh-Leylakoohi F, Azari H, Dashtiahangar M, Fiuji H, Yousefli Z, Asadnia A, Maftooh M, et al. The diagnostic and prognostic value of C1orf174 in colorectal cancer. Bioimpacts. 2024;15:30566. https:\/\/doi.org\/10.34172\/bi.30566.","journal-title":"Bioimpacts"},{"key":"3785_CR48","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1038\/s41420-022-01140-z","volume":"8","author":"Y Gao","year":"2022","unstructured":"Gao Y, Chen B, Wang R, Xu A, Wu L, Lu H, Zhao G. Knockdown of RRM1 in tumor cells promotes radio-\/chemotherapy induced ferroptosis by regulating p53 ubiquitination and p21-GPX4 signaling axis. Cell Death Discov. 2022;8:343. https:\/\/doi.org\/10.1038\/s41420-022-01140-z.","journal-title":"Cell Death Discov"},{"key":"3785_CR49","doi-asserted-by":"publisher","unstructured":"Sun L, Zhao P, Chen M, Leng J, Luan Y, Du B, Yang J, Yang Y, Rong R. Taxanes prodrug-based nanomedicines for cancer therapy. J Control Release. 2022;348:672\u201391. https:\/\/doi.org\/10.1016\/j.jconrel.2022.06.004.","DOI":"10.1016\/j.jconrel.2022.06.004"},{"key":"3785_CR50","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1186\/s12951-025-03310-4","volume":"23","author":"M Fang","year":"2025","unstructured":"Fang M, Cao L, Zhang Z, Yu Z, Shen Y, Chen J, Chen J, Li YQ, Liu Z, Meng Y, et al. Blocking copper transporter protein-dependent drug efflux with albumin-encapsulated Pt(IV) for synergistically enhanced chemo-immunotherapy. J Nanobiotechnol. 2025;23:217. https:\/\/doi.org\/10.1186\/s12951-025-03310-4.","journal-title":"J Nanobiotechnol"},{"key":"3785_CR51","doi-asserted-by":"publisher","unstructured":"Barenholz Y. Doxil\u00ae--the first FDA-approved nano-drug: lessons learned. J Control Release. 2012;160:117\u201334. https:\/\/doi.org\/10.1016\/j.jconrel.2012.03.020.","DOI":"10.1016\/j.jconrel.2012.03.020"},{"key":"3785_CR52","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1186\/s12951-022-01282-3","volume":"20","author":"M Wang","year":"2022","unstructured":"Wang M, Hu Q, Huang J, Zhao X, Shao S, Zhang F, Yao Z, Ping Y, Liang T. Engineered a dual-targeting biomimetic nanomedicine for pancreatic cancer chemoimmunotherapy. J Nanobiotechnol. 2022;20:85. https:\/\/doi.org\/10.1186\/s12951-022-01282-3.","journal-title":"J Nanobiotechnol"},{"key":"3785_CR53","doi-asserted-by":"publisher","first-page":"2238","DOI":"10.1021\/acs.jmedchem.3c01749","volume":"67","author":"T Shi","year":"2024","unstructured":"Shi T, Chen X, Ti H. Ferroptosis-based therapeutic strategies toward precision medicine for cancer. J Med Chem. 2024;67:2238\u201363. https:\/\/doi.org\/10.1021\/acs.jmedchem.3c01749.","journal-title":"J Med Chem"},{"key":"3785_CR54","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1186\/s12951-021-00952-y","volume":"19","author":"X Wang","year":"2021","unstructured":"Wang X, Wu M, Zhang X, Li F, Zeng Y, Lin X, Liu X, Liu J. Hypoxia-responsive nanoreactors based on self-enhanced photodynamic sensitization and triggered ferroptosis for cancer synergistic therapy. J Nanobiotechnol. 2021;19:204. https:\/\/doi.org\/10.1186\/s12951-021-00952-y.","journal-title":"J Nanobiotechnol"},{"key":"3785_CR55","doi-asserted-by":"publisher","unstructured":"Zhuang Y, Li L, Feng L, Wang S, Su H, Liu H, Liu H, Wu Y. Mitochondrion-targeted selenium nanoparticles enhance reactive oxygen species-mediated cell death. Nanoscale. 2020;12:1389\u201396. https:\/\/doi.org\/10.1039\/C9NR09039H.","DOI":"10.1039\/C9NR09039H"},{"key":"3785_CR56","doi-asserted-by":"publisher","unstructured":"Cao Z, Liu X, Zhang W, Zhang K, Pan L, Zhu M, Qin H, Zou C, Wang W, Zhang C, et al. Biomimetic macrophage membrane-camouflaged nanoparticles induce ferroptosis by promoting mitochondrial damage in glioblastoma. ACS Nano. 2023;17:23746\u201360. https:\/\/doi.org\/10.1021\/acsnano.3c07555.","DOI":"10.1021\/acsnano.3c07555"}],"container-title":["Journal of Nanobiotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-025-03785-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12951-025-03785-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-025-03785-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,25]],"date-time":"2025-11-25T21:02:46Z","timestamp":1764104566000},"score":1,"resource":{"primary":{"URL":"https:\/\/jnanobiotechnology.biomedcentral.com\/articles\/10.1186\/s12951-025-03785-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,25]]},"references-count":56,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3785"],"URL":"https:\/\/doi.org\/10.1186\/s12951-025-03785-1","relation":{},"ISSN":["1477-3155"],"issn-type":[{"value":"1477-3155","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,25]]},"assertion":[{"value":"25 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The Experimental Animal Center at China Medical University approved all the animal experiments (Approval number: CMU20240820).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"We give our consent for the manuscript to be published in Journal of Nanobiotechnology.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"735"}}